U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
Patritumab Deruxtecan
INN   USAN  
Official Name English
ANTI-HER3 ANTIBODY-DRUG CONJUGATE U3 1402
Common Name English
patritumab deruxtecan [INN]
Common Name English
U3-1402A
Code English
PATRITUMAB DERUXTECAN [JAN]
Common Name English
Immunoglobulin G1, anti-(human epidermal growth factor receptor HER3) (human monoclonal U3-1287 γ1-chain), complex with human monoclonal U3-1287 κ-chain, dimer, octakis(thioether) with N-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]glycylglycyl-
Common Name English
U31402
Code English
Patritumab deruxtecan [WHO-DD]
Common Name English
U3-1402
Code English
Immunoglobulin G1-kappa, anti-[Homo sapiens ERBB3 (receptor tyrosine-protein kinase erbB-3, HER3)], Homo sapiens monoclonal antibody, conjugated to deruxtecan, comprising a linker and a camptothecin derivative; gamma1 heavy chain Homo sapiens (1-447) [VH
Common Name English
PATRITUMAB DERUXTECAN [USAN]
Common Name English
Code System Code Type Description
INN
11093
Created by admin on Sat Dec 16 14:22:07 UTC 2023 , Edited by admin on Sat Dec 16 14:22:07 UTC 2023
PRIMARY
USAN
KL-231
Created by admin on Sat Dec 16 14:22:07 UTC 2023 , Edited by admin on Sat Dec 16 14:22:07 UTC 2023
PRIMARY
CAS
2227102-46-5
Created by admin on Sat Dec 16 14:22:07 UTC 2023 , Edited by admin on Sat Dec 16 14:22:07 UTC 2023
PRIMARY
FDA UNII
3XPI7EG4W8
Created by admin on Sat Dec 16 14:22:07 UTC 2023 , Edited by admin on Sat Dec 16 14:22:07 UTC 2023
PRIMARY
NCI_THESAURUS
C136987
Created by admin on Sat Dec 16 14:22:07 UTC 2023 , Edited by admin on Sat Dec 16 14:22:07 UTC 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966